Clinical Trials Browser

Withdrawn × OTHER × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all

NCT05321940 2023-12-04

Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00935558 2012-05-31

Dendritic Cell Based Therapy for Breast Cancer Patients

Phase 2 Withdrawn

Breast Neoplasms